Manufacturers Life Insurance Company, The Organogenesis Holdings Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 28,701 shares of ORGO stock, worth $88,112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,701
Previous 29,650
3.2%
Holding current value
$88,112
Previous $84,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ORGO
# of Institutions
124Shares Held
62MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$38.3 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$36.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$15.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$11 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$9.47 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $402M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...